The outlook of companies tied to the drug's history presents a complex investment landscape. While the initial success generated substantial gains, generic copies have significantly impacted sales . Investing in related pharmaceutical firms now requires a discerning assessment of intellectual property rights , evolving healthcare Adult shifts , and